← Home / DANAHER CORPORATION (DHR)
Stock Analysis
DANAHER CORPORATION (DHR)
DHR
DHR · Healthcare • Life Sciences Tools
195.07 -0.56%
Track DHR in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when DHR price is:
52W Range Position
41%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-07-31 23:54 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 197.37. Holding above 190.38 keeps the current thesis intact.
⚖️
✓
Fundamentals
Improving / Positive
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
190.38
↗
Break Above
Confirmation improves above resistance.
197.37
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 190.38
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
21
●
Financial Results
HIGH
Danaher Reports Second Quarter 2026 Results
Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2026.
8-K Filing • SEC EDGAR
JUN
3
$
Debt Financing
HIGH
DHR debt financing update
Reference is made to the disclosure set forth under ITEM 8.01 OTHER EVENTS.
8-K Filing • SEC EDGAR
MAY
7
●
Management / Board
MEDIUM
DHR board and management update
At the annual meeting, the Company’s shareholders voted on the following proposals: 1.
8-K Filing • SEC EDGAR
What's Driving DHR?
📈 Technical recovery is improving
Momentum is Neutral. Watch 197.37 for confirmation and 190.38 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 190.38 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend line not broken yet · score 17
Trigger
203.60
Invalidation
203.60
RSI(14)
52.4
◎
How to read this setup
The nearest decision zone is framed by support around 190.38 and resistance near 197.37. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
DHR — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Fair
Fair valuation
The earnings multiple is in a moderate range.
Market Cap
$137.1B
Company size
EV
$158.0B
Debt-adjusted value
P/E
34.2
Reasonable
P/S
5.5
Balanced
P/B
2.6
Balanced
EV/Sales
6.3
Balanced
EV/EBIT
30.8
Reasonable
P/FCF
25.1
Reasonable
FCF Yield
3.99%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Improving financial execution
Growth, profitability, cash flow and balance sheet quality remain broadly supportive.
↗
Revenue Growth
Improving
●
Profitability
Positive
≈
Cash Flow
Positive
⚖
Balance Sheet
Strong
💵 Revenue
6.26B
↗ Improving
📈 Net Income
870.00M
↗ Positive
🧮 EPS (Basic)
1.23
↗ Positive
DANAHER CORPORATION
Healthcare • Life Sciences Tools
Related Opportunities